GoodRx Holdings (GDRX) Return on Invested Capital (2020 - 2026)

GoodRx Holdings (GDRX) has 7 years of Return on Invested Capital data on file, last reported at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), and the FY2025 full-year result was 0.09%, up 4.0% from the prior year.
• Return on Invested Capital fell to 0.02% in Q1 2026, from 0.02% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.04% in Q3 2024 to a low of 0.05% in Q2 2022.
• A 5-year average of 0.01% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital gained 16 bps in 2022 and slipped 2 bps in 2023, its largest moves.
• Tracing GDRX's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then plunged by 270 bps to 0.0% in 2023, then soared by 1034 bps to 0.01% in 2024, then soared by 70 bps to 0.02% in 2025, then dropped by 25 bps to 0.02% in 2026.
• Business Quant data shows GDRX's Return on Invested Capital at 0.02% in Q1 2026, 0.02% in Q4 2025, and 0.03% in Q3 2025.